Evaluation and management of lymphoma and leukemia in pregnancy.
Cancer complicates roughly 1 in 1000 pregnancies with roughly 18% of these cases represented by the hematologic malignancies. These can range from an indolent lymphoma requiring only close monitoring to acute, life-threatening, processes requiring emergent therapy, and evaluation for potential termination of the pregnancy. Management of a pregnant woman with a hematologic malignancy requires a multidisciplinary approach combining the expertise of hematologists, obstetricians, and perinatologists to accomplish the best possible outcome. Many women are able to be treated successfully and deliver healthy babies.
Department of Internal Medicine, Division of Hematology, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, Columbus, Ohio, USA.
Jonathon B
JB
Cohen
Kristie A
KA
Blum
D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000628:therapy*